Name | Title | Contact Details |
---|
Welcome to Anteriad! MeritB2B, True Influence, and other strategic acquisitions have combined to form Anteriad, a trailblazer in B2B marketing. Best-in-class offerings include demand gen, marketing cloud tech, leading intent, programmatic, and audience solutions – all powered by the industry`s most comprehensive B2B data.
Moat is a SaaS analytics company focused on transforming brand advertising online. Moat`s products include Moat Ad Search, Moat Pro and Moat Analytics. Moat Ad Search is a free display ad search engine. Moat Pro is an industry wide real-time search solution providing insights across brands, publishers, and ad tech. Moat Analytics is a proprietary solution for advertisers and publishers to measure ad effectiveness and content engagement, exposing a new lens of attention measurement that moves beyond traditional digital metrics.
We specialize in helping B2B sales organizations with their number one challenge; generating qualified prospects. We have built an inside sales team for-hire that becomes the lead generation engine for our clients; providing a consistent flow of qualified leads or appointments.
Demand Media, Inc. (NYSE: DMD) is a diversified internet company that builds platforms across our media (eHow and LIVESTRONG.com) and marketplace (Society6 and Saatchi Art) properties to enable communities of creators to reach passionate audiences in large and growing lifestyle categories. In addition, Demand Media`s custom content solutions (studioD) and diverse advertising offerings help advertisers find innovative ways to engage with their customers.
Inspira Marketing Group is an experiential marketing agency specializing in reaching consumers, fostering meaningful connections and propelling brands forward. Located in Norwalk, CT, the agency was founded for one reason: to do great work that leads to great things. Inspira delivers award-winning campaigns for clients such as Microsoft, Diageo and Life Is Good, while devoting a portion of its profits to find a cure for pediatric cancer.